Molinette Hospital
Città della Salute e della Scienza di Torino
Aula Lenti – Dip.to Scienze Mediche
PRESIDENT – P. Gontero
COORDINATOR – F. Soria
PROVIDER ECM
Università degli Studi di Torino
Provider accreditato Age.Na.S. N. 173
ORGANIZING SECRETARIAT
Symposia Organizzazione Congressi Srl
Provider accreditato Age.Na.S. N. 486
Piazza Campetto 2/8 – 16123 Genova
8.30 Welcome and Introduction P. Gontero, M. Airoldi, U. Ricardi
9.00-10.00 Live surgery session 1
Moderators: M. Brausi, A. Lapini
Theatre coordinator: F. Soria, B. Lillaz
Theatre A: En bloc resection with Thulium Laser M. Moschini
Theatre B: Totally laparoscopic extraperitoneal NUT – Port placement and retroperitoneal access P. Gontero, M. Allasia
Lectures – Session 1
Moderators V. Ficarra, A. Volpe
10.00 Lecture: “The importance of the high-quality TUR” B. Pradere
10.15 Lecture: “Intermediate risk NMIBC: a clinical dilemma” A. Antonelli
10.30 Lecture: “New horizons in the treatment of BCG-unresponsive NMIBC” F. Soria
10.45 Discussion
11.00-12.00 Live surgery session 2
Moderators: G. Simone, A. Tubaro
Theatre A: KSS for low-risk UTUC: new technologies A. Bosio
Theatre B: Totally laparoscopic extraperitoneal NUT – Distal ureter and bladder cuff P. Gontero, M. Allasia
12.00 Lecture: “KSS: from patients’ selection to adjuvant treatment and follow up” R. Naspro
12.15 Round table: Milestones in primary management of NMIBC A. Tubaro, A. Lapini, P. Gontero
– Introduction: points of controversies (results of a National survey)
Flash lectures (5 min each):
+ Standard of care in diagnosis of BC 2023 A. Tubaro
+ BCG when and how A. Lapini
+ Optimal use of intravesical chemotherapy A. Lapini
Discussion: is BCG shortage still a problem?
12.45 Discussion
13.00 Lunch
Lectures – Session 2
Moderators: M. Airoldi, P. Giannatempo, M. Brausi
14.00 Lecture: “Neoadjuvant vs Adjuvant systemic therapy in high-risk UTUC” M. Icardi
14.15 Lecture: “Bladder sparing strategies after NAC: fact or fiction?” G. Simone
14.30 Lecture: “Surgery for oligometastatic bladder cancer: where do we stand” V. Ficarra
14.45 Discussion
Lectures – Session 3
Moderators: C. Ortega, A. Tubaro, U. Ricardi
15.00 Lecture: “High risk MIBC treated with RC: is it NAC sufficient?” D. Raggi
15.15 Lecture: “The optimal candidate for TMT” G. Iorio
15.30 Lecture: “Current role of immunotherapy in MIBC” C. Ortega
15.45 Discussion
16.00 Round Table: “Difficult cases in urothelial cancer” C. Fiori, A. Porreca, G. Iorio
16.45 Lecture: New treatment options in metastatic bladder cancer P. Giannatempo
17.00 Lecture: The role and current positioning of PaLiNUro Association in Italy E. Fiorini
17.15 Conclusions M. Airoldi, P. Gontero, U. Ricardi
Il questionario ECM sarà consegnato ai partecipanti in sede congressuale.
Si rammenta ai partecipanti all’evento che l’acquisizione dei crediti formativi ECM è subordinata all’effettiva partecipazione ad almeno il 90% del programma formativo ed alla verifica del test di apprendimento (superamento del questionario con una percentuale di risposte corrette non inferiore al 75% del totale delle domande).
Symposia Organizzazione Congressi Srl
Piazza Campetto 2/8
16123 Genova
Tel. 010 255146 r.a.
symposia@symposiacongressi.com
P.IVA 03849570100